Oric Pharmaceuticals, Inc. (ORIC) stock
ORICNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.50−0.50 (-5.56%)
Close on Nov 12, 2026Market cap $881.05MP/E –Yield –
Oric Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oric Pharmaceuticals's enterprise value was $667.97M on Nov 11, 2026, against $868.52M a year earlier. Over the last 5 years it ranged from -$121.40M to $1.13B, with a median of $297.04M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $667.97M | +31.3% |
| 2025 | Dec 31, 2025 | $508.59M | +71.2% |
| 2024 | Dec 31, 2024 | $297.04M | +8.2% |
| 2023 | Dec 29, 2023 | $274.48M | +595.9% |
| 2022 | Dec 30, 2022 | $39.44M | -86.3% |
| 2021 | Dec 31, 2021 | $288.66M | -65.9% |
| 2020 | Dec 31, 2020 | $847.34M | – |
See a number that looks wrong?